Value through Innovation27 July 2016

Clinical Study Results

  • TRADJENTA ® - Diabetes Mellitus, Type 2
    Clinical Study Number 1218.22
    Study Indication Diabetes Mellitus, Type 2
    Product TRADJENTA ®
    Generic Name Linagliptin
    Lab Code
    Clinical Phase IV
    Study Title

    A multicenter, international, randomized, parallel group, double-blind, placebo-controlled CArdiovascular Safety & Renal Microvascular outcomE study with LINAgliptin, 5 mg once daily in patients with type 2 diabetes mellitus at high vascular risk. CARMELINA

    Study Document Lay summary 1218.22 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.